{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-000009","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2025-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.407073+00:00","generated_at":"2026-05-28T13:09:53.216205+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Lexaria Bioscience enters new exec agreement with President/CSO Docherty; base salary, 50% bonus, 15-mo severance","bullets":["New agreement effective Jan 1, 2025, replaces prior 2022 pact; Docherty remains President and Chief Scientific Officer.","Base salary subject to 5% annual increases on Jan 1, 2026 and Jan 1, 2027; performance bonuses up to 50% of base.","Change of control: up to 24 months base salary plus 2% of affiliate sale value, payable within 90 days.","Severance without cause or for good reason: 15 months base salary, increasing by 1 month per additional year to max 24 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-000009","json":"https://secwatch.observer/filing/0001640334-25-000009.json","markdown":"https://secwatch.observer/filing/0001640334-25-000009.md","text":"https://secwatch.observer/filing/0001640334-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425000009/0001640334-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425000009/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T13:09:53.216205+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}